Hand-foot syndrome Bilder
Zum Fachartikel Hand-foot syndrome
hand-foot syndrome: occurred under therapy with tyrosine kinase inhibitor. painful, extensive, persistent redness. hollow foot region uninvolved.
hand-foot syndrome: occurred under therapy with tyrosine kinase inhibitor. painful, extensive, persistent redness. hollow foot region uninvolved.
Hand-foot syndrome: after combined chemotherapy. grade 3: extensive blistering; oozing, coarse lamellar desquamation; ulcerations, severe pain; considerable discomfort that makes everyday business impossible.
Hand-foot syndrome: after chemotherapy. grade 3: extensive blistering; oozing, coarse lamellar desquamation; ulcerations, severe pain. considerable discomfort that makes everyday business impossible.
Hand-foot syndrome: after chemotherapy. grade 3: extensive blistering; oozing, coarse lamellar desquamation; ulceration, severe pain.
Hand-foot syndrome: acute, drug-induced, painful erythema in the palmar and plantar area; typical drug history for anthracyclines (doxorubicin).